JP2006137778A5 - - Google Patents

Download PDF

Info

Publication number
JP2006137778A5
JP2006137778A5 JP2006033099A JP2006033099A JP2006137778A5 JP 2006137778 A5 JP2006137778 A5 JP 2006137778A5 JP 2006033099 A JP2006033099 A JP 2006033099A JP 2006033099 A JP2006033099 A JP 2006033099A JP 2006137778 A5 JP2006137778 A5 JP 2006137778A5
Authority
JP
Japan
Prior art keywords
zolpidem hemitartrate
acid
zolpidem
forming
halide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006033099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006137778A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006137778A publication Critical patent/JP2006137778A/ja
Publication of JP2006137778A5 publication Critical patent/JP2006137778A5/ja
Pending legal-status Critical Current

Links

JP2006033099A 2000-04-24 2006-02-09 ゾルピデムヘミタートレイト Pending JP2006137778A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19929800P 2000-04-24 2000-04-24
US20602500P 2000-05-22 2000-05-22
US22536400P 2000-08-14 2000-08-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001577956A Division JP2003531173A (ja) 2000-04-24 2001-04-24 ゾルピデムヘミタートレイト

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006177160A Division JP2006249105A (ja) 2000-04-24 2006-06-27 ゾルピデムヘミタートレイト

Publications (2)

Publication Number Publication Date
JP2006137778A JP2006137778A (ja) 2006-06-01
JP2006137778A5 true JP2006137778A5 (https=) 2006-08-10

Family

ID=27394001

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001577956A Withdrawn JP2003531173A (ja) 2000-04-24 2001-04-24 ゾルピデムヘミタートレイト
JP2006033099A Pending JP2006137778A (ja) 2000-04-24 2006-02-09 ゾルピデムヘミタートレイト
JP2006177160A Pending JP2006249105A (ja) 2000-04-24 2006-06-27 ゾルピデムヘミタートレイト

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001577956A Withdrawn JP2003531173A (ja) 2000-04-24 2001-04-24 ゾルピデムヘミタートレイト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006177160A Pending JP2006249105A (ja) 2000-04-24 2006-06-27 ゾルピデムヘミタートレイト

Country Status (21)

Country Link
US (8) US20020077332A1 (https=)
EP (1) EP1292304B1 (https=)
JP (3) JP2003531173A (https=)
KR (1) KR20030069796A (https=)
AT (4) ATE335481T1 (https=)
AU (2) AU5721301A (https=)
CA (1) CA2406982A1 (https=)
CZ (1) CZ20023775A3 (https=)
DE (7) DE04010651T1 (https=)
DK (1) DK1292304T3 (https=)
ES (4) ES2238941T3 (https=)
HR (1) HRP20020909A2 (https=)
HU (1) HUP0300701A2 (https=)
IL (1) IL152411A0 (https=)
NZ (1) NZ522015A (https=)
PL (1) PL358548A1 (https=)
PT (3) PT1541146E (https=)
SE (1) SE5292304T3 (https=)
SK (1) SK16372002A3 (https=)
WO (1) WO2001080857A1 (https=)
YU (1) YU79402A (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001284322A1 (en) 2000-08-29 2002-03-13 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
EP1575952B1 (en) 2002-12-18 2009-02-18 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
WO2004087703A1 (en) * 2003-03-12 2004-10-14 Sun Pharmaceutical Industries Limited Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
JP5179757B2 (ja) * 2004-02-17 2013-04-10 トランセプト ファーマシューティカルズ， インコーポレイティド 口腔粘膜を介して催眠剤をデリバリーするための組成物及びその使用方法
WO2006008636A2 (en) * 2004-07-16 2006-01-26 Ranbaxy Laboratories Limited Processes for the preparation of zolpidem and its hemitartrate
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
EP1883408A4 (en) * 2005-05-25 2009-11-11 Transcept Pharmaceuticals Inc SOLID COMPOSITIONS AND METHODS FOR TREATMENT OF INSOMNIA IN THE NIGHT
KR20080038416A (ko) * 2005-08-19 2008-05-06 아벤티스 파마슈티칼스 인크. 수면제와 치환된 비스 아릴 및 헤테로아릴 화합물의 배합물및 이의 치료요법적 용도
AU2006283702A1 (en) * 2005-08-19 2007-03-01 Aventis Pharmaceuticals Inc. Comination of a hypnotic agent and R(+)-alpha-(2,3-dimethoxy-phenyl)-1-(2-(4-fluorophenl)ethyl)-4-piperidinemethanol and therapeutic application thereof
EP1948655A1 (en) * 2005-10-03 2008-07-30 Mallinckrodt, Inc. Process for preparing zolpidem hemitartrate and tartrate polymorphs
WO2007047047A2 (en) * 2005-10-17 2007-04-26 Mallinckrodt Inc. Polymorph transformation of zolpidem in tablet matrix
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
WO2007117399A2 (en) 2006-03-31 2007-10-18 Janssen Pharmaceutica N.V. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
WO2008067549A2 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized zolpidem pharmaceutical compositions
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
SG192446A1 (en) * 2008-06-30 2013-08-30 Janssen Pharmaceutica Nv Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
WO2011066352A1 (en) 2009-11-27 2011-06-03 Genzyme Corporation An amorphous and a crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
PT2964229T (pt) 2013-03-06 2020-03-23 Janssen Pharmaceutica Nv Moduladores de piridina benzimidazol-2-ilo do recetor h4 de histamina
CN116283957A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦水合物及其制备方法
CN116283958B (zh) * 2021-12-03 2026-02-24 山东新时代药业有限公司 唑吡坦共晶体及其制备方法
CN117907368A (zh) * 2024-01-27 2024-04-19 鲁南贝特制药有限公司 一种酒石酸唑吡坦药用晶型d中晶型a、e的定量测定方法
CN118750459B (zh) * 2024-07-22 2025-04-01 常州市武进中医医院 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
DE3018940A1 (de) * 1980-05-17 1981-11-26 Hoechst Ag, 6000 Frankfurt Verwendung eines vinylchlorid-pfropf-copolymerisates in der plastisolverarbeitung
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2525601A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
US4675323A (en) * 1985-08-06 1987-06-23 Synthelabo Imidazo(1,2-a)quinoline derivatives useful as anxiolytic agents
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
EP0289371B1 (fr) * 1987-03-27 1991-09-25 Synthelabo Dérivés d'imidazopyridines, leur préparation et leur application en thérapeutique
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
IT1276522B1 (it) * 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
PT1038875E (pt) * 1999-03-25 2003-10-31 Synthon Bv Derivados de imidazopiridina e processo para os preparar
ATE297924T1 (de) * 1999-03-25 2005-07-15 Synthon Bv Zolpidem salze
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Similar Documents

Publication Publication Date Title
JP2006137778A5 (https=)
KR102230628B1 (ko) 보르티옥세틴 제조 방법
TW201706271A (zh) 調節蛋白質激酶之化合物的合成
JP2006519818A5 (https=)
JP2007308494A (ja) 結晶イマチニブ塩基及びその製造方法
JP2013049690A5 (https=)
JP2014524442A5 (https=)
JP2016121177A5 (https=)
JP2005520803A5 (https=)
JP2010511649A5 (https=)
CN103570633B (zh) 吉非替尼的制备方法
JP2018522945A5 (https=)
CN101921260B (zh) 一种伊马替尼的制备方法
WO2017092703A1 (zh) 制备无定型奥贝胆酸的方法
JP2010520251A5 (https=)
TWI551603B (zh) 培美曲塞二酸之晶型及其製備方法
US20170008848A1 (en) Methods of making netupitant and intermediates thereof
CN106470984B (zh) 制备吡虫啉多晶型的方法
JP2005513122A5 (https=)
JP2020083892A5 (https=)
JP2020517674A (ja) ボルチオキセチンＨＢｒ α型を製造するための方法
JP2007502883A5 (https=)
CN114258394A (zh) 一种致癌性融合激酶抑制剂的晶型及其应用
CN114315773B (zh) 一种哌嗪化合物及其制备方法
CN107056860A (zh) 2－肼基腺苷及其制备方法